2011
DOI: 10.1016/j.amjmed.2011.04.019
|View full text |Cite
|
Sign up to set email alerts
|

Dose-related Effect of Statins in Venous Thrombosis Risk Reduction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
26
1

Year Published

2011
2011
2015
2015

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(28 citation statements)
references
References 35 publications
1
26
1
Order By: Relevance
“…Besides having a lipidlowering effect, a statin is associated with a reduction in all causes of death from non-obstructive coronary artery disease [4]. Additionally, some authors have found it to have a positive effect on vascular inflammation [5], and linked it to a lower risk of developing venous thromboembolism [6].…”
Section: Introductionmentioning
confidence: 99%
“…Besides having a lipidlowering effect, a statin is associated with a reduction in all causes of death from non-obstructive coronary artery disease [4]. Additionally, some authors have found it to have a positive effect on vascular inflammation [5], and linked it to a lower risk of developing venous thromboembolism [6].…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, novel treatments targeting endothelial dysfunction or atherosclerotic inflammation might be safer and, thus, should be investigated in both primary and secondary prevention of VTE. For instance, treatment with statins has been shown to markedly reduce the risk of venous thrombosis in a dose-related manner (16). Importantly, this beneficial effect was further improved by concomitant treatments with an antiplatelet drug (16), indicating that combined anti-atherosclerotic treatment might selectively improve also VTE.…”
Section: Invited Editorial Focusmentioning
confidence: 97%
“…5). In contrast to other lipid-lowering drugs, statins are therapeutic and also preventative against VTE among at-risk medical inpatients and also general population in a dose-dependent manner, however this effect has not been observed in elderly population [93,[96][97][98][99][100][101].…”
Section: Temporality Of Inflammatory Events Following Ptementioning
confidence: 99%